Thyropropic acid
Drug profile
Also known as: atralose, birodan, triopron, triprop
Data last refreshed: (DrugCentral release 2024-11-01)
Key facts
Thyropropic acid is a drug catalogued in DrugCentral. DrugCentral lists 3 molecular targets, including THRB, THRA and PCNA.
- Molecular targets: THRB, THRA and PCNA (3 listed in DrugCentral).
- Molecular formula: C15H11I3O4; molecular weight 635.96 g/mol.
Mechanism & targets
Molecular targets (3)
| Target | Gene | Action | Activity |
|---|---|---|---|
| Thyroid hormone receptor beta | THRB | unknown | IC50 10.72 |
| Thyroid hormone receptor alpha | THRA | unknown | IC50 10.39 |
| Proliferating cell nuclear antigen | PCNA | unknown | IC50 4.77 |
Chemical structure
Full physicochemical, ADMET and 3D-structure analysis of Thyropropic acid is on its molecule page.
| Molecular formula | C15H11I3O4 |
|---|---|
| Molecular weight | 635.96 g/mol |
| CAS number | 51-26-3 |
| InChIKey | VRORTNGXAKZJML-UHFFFAOYSA-N |
| PubChem CID | 5804 |
Frequently asked questions
Answers are generated from the structured data on this page, not written by hand.
How does Thyropropic acid work?
Its molecular targets in DrugCentral include THRB, THRA and PCNA.
What is the chemical formula of Thyropropic acid?
Thyropropic acid has the molecular formula C15H11I3O4 and a molecular weight of 635.96 g/mol.
Browse: all drugs starting with T · drug guides by category · protein targets A–Z.
Sources
- DrugCentral drug card 3604 — structure, indications, targets, approvals, pharmacologic classes (CC BY-SA 4.0)
- ChEMBL CHEMBL291053 — compound record and bioactivity
- PubChem CID 5804 — chemical identifiers
- FDA UNII OK7481S22O — substance identity
- UniProt P10828 (THRB) — target protein
- UniProt P10827 (THRA) — target protein
- UniProt P12004 (PCNA) — target protein
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.